Page last updated: 2024-10-29

ketoconazole and African Lymphoma

ketoconazole has been researched along with African Lymphoma in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanda, N1
Watanabe, S1
Berkowitz, RJ1
Hughes, C1
Rudnick, M1
Gordon, EM1
Strandjord, S1
Cheung, NK1
Warkentin, P1
Coccia, PF1

Other Studies

2 other studies available for ketoconazole and African Lymphoma

ArticleYear
Ketoconazole suppresses interleukin-4 plus anti-CD40-induced IgE class switching in surface IgE negative B cells from patients with atopic dermatitis.
    The Journal of investigative dermatology, 2002, Volume: 119, Issue:3

    Topics: Adenylyl Cyclases; Adult; Antifungal Agents; B-Lymphocytes; Burkitt Lymphoma; CCAAT-Enhancer-Binding

2002
Oropharyngeal Candida prophylaxis in pediatric bone marrow transplant patients.
    The American journal of pediatric hematology/oncology, 1985,Spring, Volume: 7, Issue:1

    Topics: Adolescent; Anemia, Aplastic; Bone Marrow Transplantation; Burkitt Lymphoma; Candidiasis; Child; Chi

1985